FDA Inspection 1191865 — Eurofins Biopharma Product Testing Australia Pty. Ltd.
The FDA completed an inspection of Eurofins Biopharma Product Testing Australia Pty. Ltd. on Nov 4, 2022 in Girraween. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 4, 2022
- Fiscal Year
- 2023
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Girraween (Australia)